Silver–PEG Nanoparticle–Based Encapsulation of 5‐Fluorouracil for Enhanced Anticancer Efficacy and Controlled Drug Delivery

View at publisher Summarise with VIRAT
Authors: Subramaniam Krishnaveni, K. Parvathi, Srinivasan Ayyanaar, Mookkandi Palsamy Kesavan
Cited by: 0
References: 71

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

ABSTRACT Cancer therapy requires drug delivery systems that enhance efficacy while minimizing systemic toxicity. This study aimed to develop a multifunctional, biocompatible nanocarrier for 5‐fluorouracil (5‐FU) with pH‐responsive release and complementary biological activity. Silver nanoparticles (AgNPs) were biosynthesized using Ocimum sanctum leaf extract, functionalized with polyethylene glycol (PEG), and subsequently loaded with 5‐FU to form Ag@PEG‐5‐FU‐NPs. The structural, morphological, and thermal characteristics of the nanocarrier were confirmed by UV–Vis, FTIR, SEM, HRTEM, XRD, and TGA analyses. In vitro assays including pH‐dependent drug release, human red blood cell (HRBC) membrane stabilization, and cytotoxicity studies on A549, MDA‐MB‐231, and MCF‐7 cell lines were used to evaluate therapeutic performance. The Ag@PEG‐5‐FU‐NPs exhibited pronounced pH‐responsive behavior, with cumulative 5‐FU release reaching 84.10 ± 5.20% at pH 5.2 compared to 63.56 ± 1.25% at pH 7.4. The system also demonstrated strong anti‐inflammatory activity (IC 50 = 22.15 µg/mL) and potent anticancer effects, especially against A549 lung cancer cells (IC 50 = 11.15 µg/mL). Overall, the results highlight Ag@PEG‐5‐FU‐NPs as a promising, multifunctional nanotherapeutic platform for efficient cancer treatment.

Fields of Study & Subjects

Nanoparticle-Based Drug Delivery Nanoparticles: synthesis and applications Gold and Silver Nanoparticles Synthesis and Applications

Publication details

Journal / source
ChemistrySelect
Volume
11
Issue
12
Publication date
1 March 2026
Language
EN